- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: MDM2 Inhibitor KRT-232
Total 983 results
-
National Cancer Institute (NCI)NRG OncologyActive, not recruitingSoft Tissue Sarcoma | Resectable Soft Tissue SarcomaUnited States
-
Kartos Therapeutics, Inc.TerminatedSmall Cell Lung Carcinoma | Small-cell Lung Cancer | Small Cell Lung Cancer Extensive Stage | Small Cell Lung Cancer RecurrentGermany, Spain, France, Australia, United States, Korea, Republic of, Hungary
-
Kartos Therapeutics, Inc.UnknownPolycythemia VeraUnited States, Poland, Spain, Germany, Hungary, France
-
Kartos Therapeutics, Inc.RecruitingPrimary Myelofibrosis (PMF) | Post-Polycythemia Vera Myelofibrosis (Post-PV-MF) | Post-Essential Thrombocythemia Myelofibrosis (Post-ET-MF)United States, Mexico, Bulgaria, Poland, Russian Federation, Belarus, Georgia, South Africa, Ukraine
-
Kartos Therapeutics, Inc.GOG Foundation; European Network of Gynaecological Oncological Trial Groups...RecruitingEndometrial CancerUnited States, Austria, Spain, Israel, Denmark, Sweden, Slovenia, Finland, Georgia, Italy, Romania, Poland, Estonia, Hungary, Lithuania, Norway
-
Kartos Therapeutics, Inc.RecruitingMyelofibrosisUnited States, France, Australia, Spain, Germany, Bulgaria, Israel, Italy, Poland
-
National Cancer Institute (NCI)RecruitingAcute Myeloid Leukemia | Secondary Acute Myeloid Leukemia | Recurrent Acute Myeloid Leukemia | Refractory Acute Myeloid LeukemiaUnited States
-
National Cancer Institute (NCI)RecruitingGlioblastoma | Gliosarcoma | Recurrent Glioblastoma | MGMT-Unmethylated GlioblastomaUnited States
-
Kartos Therapeutics, Inc.Telios Pharma, Inc.RecruitingPrimary Myelofibrosis | Myelofibrosis | Post-PV MF | Post-ET MyelofibrosisUnited States, Italy, Serbia, Poland, France, Austria, Bulgaria, Germany, Hungary, Spain
-
Telios Pharma, Inc.Kartos Therapeutics, Inc.Active, not recruitingAcute Myeloid LeukemiaUnited States, Korea, Republic of, Spain, France, Austria, Australia, Germany, Italy
-
Kartos Therapeutics, Inc.RecruitingChronic Lymphocytic Leukemia | Non Hodgkin Lymphoma | Diffuse Large B Cell LymphomaBelgium, Korea, Republic of, United States, United Kingdom, Italy, Switzerland, Australia, France, Poland, Portugal, Czechia
-
Kartos Therapeutics, Inc.RecruitingPrimary Myelofibrosis (PMF) | Post-Polycythemia Vera MF (Post-PV-MF) | Post-Essential Thrombocythemia MF (Post-ET-MF)United States, Korea, Republic of, Germany, Australia, Hungary, France, Spain, Italy, Taiwan, Thailand, Brazil, Poland, Turkey, Israel, Portugal, Romania, Argentina, Bulgaria, Canada, Croatia, Czechia, Lithuania, Mexico, Philippines, United... and more
-
Kartos Therapeutics, Inc.RecruitingMerkel Cell CarcinomaUnited States, Netherlands, Korea, Republic of, France, Germany, Spain, Canada, Italy, Australia, Brazil
-
Kartos Therapeutics, Inc.RecruitingChronic Myeloid LeukemiaItaly, Spain, United States, Korea, Republic of, France, Poland, Canada, Russian Federation
-
Kartos Therapeutics, Inc.Withdrawn
-
National Cancer Institute (NCI)Active, not recruitingAcute Myeloid Leukemia | Acute Myeloid Leukemia Arising From Previous Myelodysplastic SyndromeUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingAnatomic Stage III Breast Cancer AJCC v8 | Anatomic Stage IIIA Breast Cancer AJCC v8 | Anatomic Stage IIIB Breast Cancer AJCC v8 | Anatomic Stage IIIC Breast Cancer AJCC v8 | Prognostic Stage III Breast Cancer AJCC v8 | Prognostic Stage IIIA Breast Cancer AJCC v8 | Prognostic Stage IIIB Breast... and other conditionsUnited States
-
Philip Morris Products S.A.Completed
-
National Cancer Institute (NCI)RecruitingPlasmacytoma | Refractory Multiple Myeloma | Recurrent Multiple MyelomaUnited States
-
Daiichi Sankyo, Inc.TerminatedMyelodysplastic Syndrome | Acute Myelogenous LeukemiaUnited States
-
SWOG Cancer Research NetworkNational Cancer Institute (NCI)Active, not recruitingStage IVA Lung Cancer AJCC v8 | Stage IVB Lung Cancer AJCC v8 | Stage IV Lung Cancer AJCC v8 | Recurrent Lung Non-Small Cell CarcinomaUnited States
-
Lawson Health Research InstituteCompleted
-
Kartos Therapeutics, Inc.TerminatedRelapsed or Refractory Acute Myeloid Leukemia (AML) | Acute Myeloid Leukemia (AML), Secondary to Myeloproliferative Neoplasms (MPN)United States, Spain, Korea, Republic of, Belgium, United Kingdom, Hungary, France, Germany, Israel, Australia, Italy, Poland
-
Statens Serum InstitutCompleted
-
Lykos TherapeuticsCompletedPosttraumatic Stress DisorderUnited States
-
Lykos TherapeuticsCompletedPosttraumatic Stress Disorder (PTSD)Israel
-
Kartos Therapeutics, Inc.CompletedAcute Myeloid Leukemia | Cancer | Oncology | Advanced Malignancy | Oncology PatientsUnited States
-
University of WashingtonNational Cancer Institute (NCI); University of Wisconsin, MadisonRecruitingAnatomic Stage IB Breast Cancer AJCC v8 | Anatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage IIA Breast Cancer AJCC v8 | Anatomic Stage IIB Breast Cancer AJCC v8 | Anatomic Stage III Breast Cancer AJCC v8 | Anatomic Stage IIIA Breast Cancer AJCC v8 | Anatomic Stage IIIB Breast Cancer AJCC... and other conditionsUnited States
-
Gyeongsang National University HospitalUnknownCOVID-19 | Corona Virus Infection
-
Kartos Therapeutics, Inc.GlaxoSmithKlineCompletedMelanoma | Cancer | Advanced Solid Tumors | Oncology | Tumors | Advanced Malignancy | Oncology PatientsUnited States, Australia
-
Lykos TherapeuticsCompletedPosttraumatic Stress DisorderUnited States
-
Germans Trias i Pujol HospitalFundació Recerca Institut Germans Trias i Pujol; Istituto Superiore di SanitàActive, not recruitingHealthy Subjects | Substance UseSpain
-
M.D. Anderson Cancer CenterBayer; Prostate Cancer FoundationCompleted
-
University Hospital, Basel, SwitzerlandRecruiting
-
CelgeneTerminatedLymphoma, Large B-Cell, DiffuseUnited States, France, Canada, Italy
-
Children's Oncology GroupNational Cancer Institute (NCI)Active, not recruitingMalignant Glioma | WHO Grade 3 Glioma | Refractory Lymphoma | Refractory Malignant Solid Neoplasm | Recurrent Lymphoma | Recurrent Malignant Solid Neoplasm | Refractory Primary Central Nervous System Neoplasm | Recurrent Childhood Central Nervous System Neoplasm | Recurrent Brain Neoplasm | Recurrent Childhood...United States
-
Kari KendraKaryopharm Therapeutics IncCompletedRecurrent MelanomaUnited States
-
Barbara Ann Karmanos Cancer InstituteNational Cancer Institute (NCI)RecruitingDiffuse Large B-Cell Lymphoma | Recurrent Mantle Cell Lymphoma | Recurrent Marginal Zone Lymphoma | Refractory B-Cell Non-Hodgkin Lymphoma | Recurrent B-Cell Non-Hodgkin Lymphoma | Refractory Mantle Cell Lymphoma | Recurrent Follicular Lymphoma | Refractory Follicular Lymphoma | Recurrent Waldenstrom... and other conditionsUnited States
-
University of California, San FranciscoNational Cancer Institute (NCI)TerminatedPSA Progression | Metastatic Prostate Carcinoma in the Soft Tissue | Hormone-Resistant Prostate Cancer | Stage IV Prostate Adenocarcinoma AJCC v7 | Castration Levels of Testosterone | Prostate Carcinoma Metastatic in the BoneUnited States
-
Immune-Onc TherapeuticsCalifornia Institute for Regenerative Medicine (CIRM)RecruitingCMML | AML With Monocytic DifferentiationUnited States
-
Sidney Kimmel Cancer Center at Thomas Jefferson...Bayer; Janssen, LP; Prostate Cancer Clinical Trials ConsortiumCompletedStage IV Prostate Adenocarcinoma | Hormone-refractory Prostate Cancer | Prostate Carcinoma Metastatic to the BoneUnited States
-
Erin BertinoKaryopharm Therapeutics IncTerminatedRecurrent Small Cell Lung CarcinomaUnited States
-
Statens Serum InstitutCompleted
-
Statens Serum InstitutCompleted
-
University Hospital, Basel, SwitzerlandCompleted
-
Dana-Farber Cancer InstituteBayerCompletedMetastatic Renal Cell CarcinomaUnited States
-
Mamta ParikhNational Cancer Institute (NCI); Karyopharm Therapeutics IncRecruitingMetastatic Urothelial Carcinoma | Locally Advanced Urothelial Carcinoma | Advanced Urothelial Carcinoma | Refractory Urothelial CarcinomaUnited States